Overview


According to FutureWise analysis the market for Skin Grafting Device is expected to register a CAGR of 5.50% from 2023-2031.

A skin transplant is a procedure for removing donor skin from an area of the body. The skin is then transferred to the desired site for the skin grafting procedure. This procedure is used to remove skin that is often hidden or covered. It is used to reduce or reverse the effects of burns, skin-based disorders, injuries, or other complications. Full-thickness skin transplants are more dangerous because the body may not accept the skin. However, it leaves only a line of scarring on the donor section. This is similar to a Cesarean-section scar. Full-thickness skin transplants will heal faster than the injury, and cause less pain than partial-thickness grafts. The advanced procedure of skin grafting covers the surgical procedure for skin replacement. This technology can be used in various situations, such as skin cancer, injury, and deep cuts. Increased cases of burn injuries, skin infections, and leg ulcers are all affecting the market for skin grafting devices. The market for skin-grafting devices is expected to grow due to increased precision and the development of electric and air dermatomes. Market growth for skin grafting devices is expected to be limited by poor healthcare access and a lack of modern healthcare infrastructure in low-income countries. The second reason is that any type of surgery on the body can cause damage to the skin in the area. This is why the skin grafts market is growing.

The skin graft market is experiencing significant growth due to the need for skin repair or removal of skin injuries, cancer, and other diseases like necrotizing fasciitis, as well as accidents. Skin grafting devices are in high demand due to the increasing incidence and severity of burn injuries, diabetic foot ulcers, pressure ulcers, and diabetic leg ulcers. The new approach to care and treatment is more holistic. It focuses not only on healing from injuries but also on improving long-term function. This trend is driving a steady increase in the demand for skin transplants and skin substitutes to treat and manage acute wounds. These procedures can be used to treat partial or full-thickness burns and play an important part in the treatment of these injuries. The skin grafting procedure can be either biological or synthetic. There are many products available for burn care. This encourages healthcare professionals such as doctors and nurses to use these options more often.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Skin Grafting Device Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Skin Grafting Device Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Organogenesis Inc
  • Specmed medical
  • Tissue Regenix Group PLC
  • Convatec Inc
  • Medtronic
  • Coloplast
  • B.Braun Melsungen AG
  • Integra Life Sciences Corporation
  • Smith and Nephew
  • AVITA Medical
  • MiMedx
  • Organogenesis Inc
  • De Soutter Medical
  • Nouvag AG

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Device Type

  • Autograft
  • Allograft

By Product Type

  • Dermatome
    • Electric Dermatome
    • Drum Dermatome
    • Others
  • Wound Debridement Devices
  • Other Devices

By Wound Type

  • Burns
  • Chronic wounds
    • Diabetic Foot ulcer
    • Pressure Ulcer
    • Venous Ulcer
  • Surgical Wounds
  • Traumatic Wounds
  • Others Wounds

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Dermatology Clinics

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Skin Grafting Device Market By Device Type, By Product Type, By Wound Type, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Skin Grafting Device Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Skin Grafting Device Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Skin Grafting Device Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Skin Grafting Device Market, By Device Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Autograft
        2. Allograft

  • 8.   Skin Grafting Device Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Dermatome
         1.1. Electric Dermatome
         1.2. Drum Dermatome
         1.3. Others
        2. Wound Debridement Devices
        3. Other Devices

  • 9.   Skin Grafting Device Market, By Wound Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Burns
        2. Chronic wounds
         1.1. Diabetic Foot ulcer
         1.2. Pressure Ulcer
         1.3. Venous Ulcer
        3. Surgical Wounds
        4. Traumatic Wounds
        5. Others Wounds

  • 10.   Skin Grafting Device Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Ambulatory Surgical Centers
        3. Dermatology Clinics

  • 11.   North America Skin Grafting Device Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Skin Grafting Device Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Skin Grafting Device Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Skin Grafting Device Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Skin Grafting Device Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Organogenesis Inc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Specmed medical
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Tissue Regenix Group PLC
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Convatec Inc
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Medtronic
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Coloplast
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. B.Braun Melsungen AG
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Integra Life Sciences Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Smith & Nephew
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. AVITA Medical
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. MiMedx
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Organogenesis Inc
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. De Soutter Medical
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Nouvag AG
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients